SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Extreme FDA Medical Device Trades: 7 Stocks Under $5
APPY
|
|
|
-29.54%
in
146 days
<> Below are extreme trades among companies with stock prices under $5 from the <font> BioMedReports.com FDA Calendar </font> , which includes 238 entries as of 7/5/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissio...
|
Updated Clinical Trial and FDA Decision Calendars
APPY
|
|
|
+29.51%
in
112 days
(closed on 07/05/09)
<> <> Below is a summary of updates to the www.BioMedReports.com database of 242 entries included in the FDA and Clinical Trial Calendars. The two web links below are for the FDA calendar home page and a recent article highlighting 14 extreme trades of companies with market caps below $200M with pending FDA decisions.
http://biomedreports <wbr> </wbr> .com/fda-calendar.ht <wbr> </wbr> ml
http://biomedreports <wbr> </wbr> .com/articles/most-p <wbr> </wbr> opular/627-trading-f <wbr> </wbr> da-decisions-14-extr <wbr> </wbr> eme-trades.html
The FDA Calenda...
|
20 Emerging Healthcare Stocks to Watch in '09
APPY
|
|
|
-77.17%
in
10 days
(closed on 01/20/09)
<> As a follow-up to my most recent article on the buyout binge among bio-pharma and diagnostic companies, below is a basket of 20 stocks (listed randomly) to consider from the ETF Innovators Indexes of 250 companies which represent a mix of pending catalysts in the form of clinical trials or FDA decisions, innovative patent portfolios or drug discovery technology platforms, promising compounds in clinical development, and marketed therapeutic or diagnostic products. Click on any of the company names for links to all of my prev...
|
Buyout Binge Begins for Bio-Pharma, Diagnostics
APPY
|
|
|
+0.00%
in
8 hours
(closed on 01/10/09)
<> 
<>
<> With news late Friday that Roche (RHHBY) is prepared to up its bid for complete control of Genentech (DNA) to $95 from a previous offer of $89 per share and a $41M ($1.50 per share) all-stock takeover offer by Sequenom (SQNM) for EXACT Sciences (EXAS); 2009 is off to a strong start for M&A activity in the bio-pharma and diagnostic space.
Larger and well funded bio-pharma and diagnostic companies are opportunistically looking to expand their product offerings, pipeline prospects, patent portfolios, ...
|
Virtual Investing at UpDown and MarketGuru
APPY
|
|
|
+0.75%
in
8 days
(closed on 01/10/09)
<>  <> The accompanying table includes the stocks in my MarketGuru virtual portfolio under MikeHavRx , which I began about one week ago.
Below is my current UpDown virtual investing portfolio, which is positioned to add some more offensive stock picks such as CME and Apple since it looks like the market rally is gaining momentum. Click on any of the company names below for a link to all of my articles.
Start earning real money with zero risk while improving your trading skills and strategies at the <> UpDow...
|
From the Blogosphere
Updated Clinical Trial and FDA Calendars
Create Your Own Diagnostics ETF
|
|
|
With HealthShares closing shop at year-end, including the former Diagnostics fund, investors who are interested in the space can create their own ETF comprised of companies from the ETF Innovators Preventive Medicine and Emerging Diagnostics Indexes. Below is a list of companies which have stocks listed for trading in the U.S. at over $1/share with a market cap of less than $10B, focusing on smaller companies which are more leveraged to diagnostics and represent possible takeover targets for larger players such as Roche (RHHBY), Abbott Labs (ABT), and Johnson & Johnson (JNJ).
However, the sm...
|
Social Investing at UpDown and MarketGuru
|
|
|
<>The accompanying table includes the stocks in my MarketGuru virtual portfolio under MikeHavRx, which I began about two weeks ago.
MarketGuru is an investor community that helps you create your ideal portfolio based on your investment philosophy and the risk level you're willing to assume. All members on the site are categorized by the risk their portfolios carry and ranked by their performance so that users can choose to follow the most appropriate investment style for their circumstances.
Start earning real money with zero risk while improving your trading skills and strategies at the <>UpDown...
|
20 Emerging Healthcare Stocks to Watch in '09
|
|
|
As a follow-up to my most recent article on the buyout binge among bio-pharma and diagnostic companies, below is a basket of 20 stocks (listed randomly) to consider from the ETF Innovators Indexes of 250 companies which represent a mix of pending catalysts in the form of clinical trials or FDA decisions, innovative patent portfolios or drug discovery technology platforms, promising compounds in clinical development, and marketed therapeutic or diagnostic products. Click on any of the company names for links to all of my previous articles for those I have mentioned previously.
<>Emerging Diagno...
|
Five Healthcare Stocks for a Happy New Year
|
|
|
<>
The accompanying table includes a basket of five small-cap stocks chosen from the ETF Innovators [ETFI] new healthcare indexes. The five companies are trading above their 50-day moving averages with expected upside catalyst(s) in the next six months or less.
AMAG Pharma (AMAG) announced last evening that the FDA issued another complete response for its iron deficiency anemia drug ferumoxytol (Feraheme). More details are expected today at 8:30 AM [ET] when AMAG will hold a conference call, but the Company stated no additional clinical trials will be required for approval and stated the follow...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on APPY |
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About AspenBio Pharma Inc.
- Answers.com
